Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171784 | SCV000055245 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Illumina Laboratory Services, |
RCV000279610 | SCV000470354 | likely benign | Congenital long QT syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000341680 | SCV000563343 | benign | Long QT syndrome | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001711460 | SCV001944472 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000171784 | SCV002074285 | likely benign | not specified | 2022-01-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253271 | SCV002524886 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002415730 | SCV002725348 | benign | Cardiovascular phenotype | 2018-11-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002253271 | SCV002805503 | likely benign | Long QT syndrome 11 | 2021-09-17 | criteria provided, single submitter | clinical testing |